Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?
Collegium Pharmaceutical Ownership Summary
Collegium Pharmaceutical is owned by 119.23% institutional investors, 1.64% insiders. Cwa asset management group is the largest institutional shareholder, holding 0% of COLL shares. Pacer US Small Cap Cash Cows 100 ETF is the top mutual fund, with 6.63% of its assets in Collegium Pharmaceutical shares.
COLL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Collegium Pharmaceutical | 119.23% | 1.64% | -20.88% |
Sector | Healthcare Stocks | 87.31% | 8.86% | 3.83% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 34.23% | 10.67% | 55.10% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Cwa asset management group | - | - | - |
Everence capital management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Cwa asset management group | - | - | - |
Everence capital management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Everence capital management | - | - | -9.80K |
Cwa asset management group | - | - | -11.23K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Cwa asset management group | - | - | -11.23K |
Everence capital management | - | - | -9.80K |
Sold Out
Holder | Change |
---|---|
Everence capital management | -9.80K |
Cwa asset management group | -11.23K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 252 | 8.15% | 38,464,415 | -2.96% | 119 | 0.79% | 141 | 8.46% | 76 | - |
Jun 30, 2024 | 233 | 0.43% | 39,636,436 | -0.49% | 122 | 0.81% | 130 | - | 76 | -3.80% |
Mar 31, 2024 | 232 | 18.97% | 39,833,483 | 1.57% | 123 | 0.84% | 130 | 42.86% | 79 | 2.60% |
Dec 31, 2023 | 195 | 11.43% | 39,219,213 | 1.31% | 121 | 0.92% | 91 | - | 77 | 28.33% |
Sep 30, 2023 | 175 | -4.37% | 38,712,156 | -1.75% | 114 | 0.89% | 91 | 12.35% | 60 | -14.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Pacer US Small Cap Cash Cows 100 ETF | 2.14M | 6.63% | -6.96K |
iShares Core S&P Small-Cap ETF | 2.08M | 6.45% | 1.07K |
Eventide Gilead N | 1.34M | 4.17% | - |
FullerThaler Behavioral Small-Cap Equity | 1.31M | 4.05% | 170.40K |
FullerThaler Behavioral Sm-Cp Eq R6 | 1.31M | 4.05% | 170.40K |
Eventide Healthcare & Life Sciences I | 1.29M | 3.99% | - |
Vanguard Total Stock Mkt Idx Inv | 979.17K | 3.04% | -16.20K |
iShares Russell 2000 ETF | 838.16K | 2.60% | -3.23K |
Principal SmallCap R5 | 598.60K | 1.86% | 12.30K |
Principal U.S. Small Cap Equity | 586.30K | 1.82% | 139.00K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 13, 2024 | Smith Thomas B | EVP and Chief Medical Officer | Sell | $351.32K |
Sep 05, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | $93.94K |
Sep 05, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | $643.26K |
Sep 06, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | $36.59K |
Jun 03, 2024 | Kuhlmann Shirley R. | EVP and General Counsel | Sell | $790.93K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | 4 |
2024 Q2 | - | 6 |
2024 Q1 | - | 4 |
2023 Q4 | - | 5 |
COLL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools